Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
OrbiMed in debut exit as TAKE Solutions inks pact to buy Ecron Acunova
Chennai-based TAKE Solutions Ltd, a business technology company focused on life sciences and supply chain management, has inked an agreement ......
Pharmaceuticals
Pharma M&A is an absolute seller's market: Alpesh Dalal of Lupin
Lupin Ltd, India's second largest drugmaker by market value, had been pursuing inorganic expansion during 2007-11, but had gone quiet ......
Healthcare
Dr Lal PathLabs gets SEBI nod for IPO
Dr Lal PathLabs Pvt Ltd, which runs the second-largest medical diagnostics services chain in the country, has received approval from ......
Healthcare
JB Chemicals to up stake in South Africa's Biotech Labs to over 95%
JB Chemicals & Pharmaceuticals Ltd said on Wednesday its board has approved a deal to buy a controlling stake in ......
Healthcare
Cipla's PE deal with Eight Roads for consumer healthcare unit hits roadblock
Mumbai-based drugmaker Cipla Ltd's proposed deal to raise private equity funding from Eight Roads Ventures (formerly Fidelity Growth Partners India) ......
Healthcare
Baring PE India sheds bulk of its holding in Indoco Remedies
Private equity firm Baring Private Equity Partners India (Baring PE India) has part-exited Indoco Remedies Ltd, a mid-sized maker of ......
Healthcare
Pfizer in merger talks with Botox maker Allergan
US drugmaker Pfizer Inc is in preliminary talks with Dublin-based Allergan plc, best known for making anti-wrinkle treatment Botox, in ......
Healthcare
India Life Sciences Fund II to back drugmaker Synergia
Private equity fund India Life Sciences Fund II (ILSF II), that is advised by investment manager InvAscent India, is close ......
Healthcare
India Quotient invests in home healthcare startup Care24
Mumbai-based home healthcare startup Aegis Care Advisors Pvt Ltd, which operates under the brand Care24, has secured $350,000 (about Rs ......
Healthcare
Cipla to sell 25% stake in Hong Kong-based biosimilars JV Biomab
Mumbai-based drugmaker Cipla Ltd has agreed to divest its entire 25 per cent equity stake in Hong Kong-based biosmilar drug ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News